Racial and ethnic differences in drug expenditures and access under Medicare Part D

Journal of Health Care for the Poor and Underserved

Volumn 22, Issue 3, 2011, Pages 1059-1074

  Chen, Jie ^a   Rizzo, John A ^b   Ortega, Alexander N ^c  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b Brook University   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Drug costs; Health care disparities; Medicaid; Medicare Part D

Indexed keywords

EID: 80051875411     PISSN: 10492089     EISSN: 15486869     Source Type: Journal    
DOI: 10.1353/hpu.2011.0070     Document Type: Article

References (35)

1. Doherty RB. Accessing the new Medicare prescription drug law. Ann Intern Med. 2004 Sep 7;141(5):391-5. Epub 2004 Jul 12.
2. Goldman DP, Joyce GF. Medicare Part D: a successful start with room for improvement. JAMA. 2008 Apr 23;299(16):1954-5.
3. Yin W, Basu A, Zhang JX, et al. The effect of the Medicare Part D prescription benefit on drug utilization and expenditures. Ann Intern Med. 2008 Feb 5;148(3):169-77. Epub 2008 Jan 7.
4. Lichtenberg FR, Sun SX. The impact of Medicare Part D on prescription drug use by the elderly. Health Aff (Millwood). 2007 Nov-Dec;26(6):1735-44.
5. Ketcham JD, Simon KI. Medicare Part D's effects on elderly patients' drug costs and utilization. Am J Manag Care. 2008 Nov;14(11 Suppl):SP14-22.
6. Bach PB, McClellan MB. The first months of the prescription-drug benefit-a CMS update. N Engl J Med. 2006 Jun 1;354(22):2312-4.
7. Joyce GF, Goldman DP, Vogt WB, et al. Medicare Part D after 2 years. Am J Manag Care. 2009 Aug;15(8):536-44.
8. Gellad WF, Huskamp HA, Phillips KA, et al. How the new medicare drug benefit could affect vulnerable populations. Health Aff (Millwood). 2006 Jan-Feb;25(1):248-55.
9. Zhang Y, Donohue JM, Lave JR, et al. The effect of Medicare Part D on drug and medical spending. N Engl J Med. 2009 Jul 2;361(1):52-61.
10. Madden JM, Graves AJ, Zhang F, et al. Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA. 2008 Apr 23;299(16):1922-8.
11. Gaskin DJ, Briesacher BA, Limcangco R, et al. Exploring racial and ethnic disparities in prescription drug spending and use among Medicare beneficiaries. Am J Geriatr Pharmacother. 2006 Jun;4(2):96-111.
12. Wang J, Zuckerman IH, Miller NA, et al. Utilizing new prescription drugs: disparities among non-Hispanic Whites, non-Hispanic Blacks, and Hispanic Whites. Health Serv Res. 2007 Aug;42(4):1499-519.
13. White-Means S. Racial patterns in disabled elderly persons' use of medical services. J Gerontol B Psychol Sci Soc Sci. 2000 Mar;55(2):S76-89.
14. Fiscella K, Franks P, Doescher MP, et al. Disparities in health care by race, ethnicity, and language among the insured: findings from a national sample. Med Care. 2002 Jan;40(1):52-9.
15. Chen J, Rizzo JA. Racial and ethnic disparities in antidepressant drug use. J Ment Health Policy Econ. 2008 Dec;11(4):155-65.
16. Kaiser Family Foundation. Dual eligibles and Medicare Part D. Washington, DC: The Kaiser Commission on Medicaid and the Uninsured, 2006.
17. Morden NE, Garrison LP. Implications of Part D for mentally ill dual eligibles: a challenge of Medicare. Health Aff (Millwood). 2006 Mar-Apr;25(2):491-500.
18. Bruen B, Holahan J. Shifting the cost of dual eligibles: implications for states and the federal government. Washington, DC: Kaiser Commission on Medicaid and the Uninsured, 2003. Available at: http://www.kff.org/medicaid/4152.cfm.
19. Crowley JS, Ashner D, Elam L. State Medicaid outpatient prescription drug policies: findings from a national survey, 2005 update. Washington, DC: The Kaiser Family Foundation, 2005.
20. The Henry J. Kaiser Family Foundation. "Spotlights" Medicare Part D trends, 2006- 2008. Washington, DC: The Henry J. Kaiser Family Foundation, 2007. Available at: http://www.kff.org/medicare/med102507pkg.cfm.
21. Centers for Medicare and Medicaid Services. Low-income subsidy. Baltimore, MD: Centers for Medicare and Medicaid Services, 2009. Available at: https://www.cms.gov/States/03_lowincomesubsidy.asp.
22. Neuman P, Cubanski J. Medicare Part D update-lessons learned and unfinished business. N Engl J Med. 2009 Jul 23;361(4):406-14.
23. Hsu J, Fung V, Price M, et al. Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs. JAMA. 2008 Apr 23; 299(16):1929-36.
24. Agency for Healthcare Research and Quality. MEPS HC-105: 2006 full year consolidated data file. Rockville, MD: Agency for Healthcare Research and Quality, 2008. Available at: http://www.meps.ahrq.gov/mepsweb/data_stats/download_data/pufs/h105/h105doc.pdf.
25. Jones AM. Health econometrics. In: Culyer AJ, Newhouse JP, eds. Handbook of health economics. Amsterdam, The Netherlands: North Holland, 2000; 265-344.
26. Craig JG. Some statistical models for limited dependent variables with application to the demand for durable goods. Econometrica. 1971 Sep;39(4):829-44.
27. Wooldridge J. Introductory econometrics: a modern approach. Cincinnati, OH: South-Western College Pub., 1999.
28. Wooldridge JM. Econometric analysis of cross section and panel data. Cambridge, MA: The MIT Press, 2000.
29. Andersen R. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995 Mar;36(1):1-10.
30. Fiscella K, Franks P, Doescher MP, et al. Disparities in health care by race, ethnicity, and language among the insured: findings from a national sample. Med Care. 2002 Jan;40(1):52-9.
31. Lê Cook B, McGuire TG, Lock K, et al. Comparing methods of racial and ethnic disparities measurement across different settings of mental health care. Health Serv Res. 2010 Jun:45(3):825-47. Epub 2010 Mar 9.
32. Ware J Jr, Kosinski M, Keller SD. A 12-item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996 Mar; 34(3):220-33.
33. Salyers MP, Bosworth HB, Swanson JW, et al. Reliability and validity of the SF-12 health survey among people with severe mental illness. Med Care. 2000 Nov;38(11):1141-50.
34. Cheak-Zamora NC, Wyrwich KW, McBride TD. Reliability and validity of the SF-12v2 in the medical expenditure panel survey. Qual Life Res. 2009 Aug;18(6):727-35. Epub 2009 May 8.
35. Santerre RE, Neun SP. Health economics: theory, insights, and industry studies. Mason, OH: South-Western Cangage Learning, 2009.